Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin-Reference-Cited by-同舟云学术

Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin

Published:2024-03 Issue: Volume:391 Page:110908
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Navarro-Carrasco Elena^ORCID,Campos-Díaz Aurora^ORCID,Monte-Serrano Eva^ORCID,Rolfs Frank,de Goeij-de Haas Richard^ORCID,Pham Thang V.^ORCID,Piersma Sander R.^ORCID,Jiménez Connie R.^ORCID,Lazo Pedro A.^ORCID

Funder

Universidad de Salamanca

Publisher

Elsevier BV

Reference61 articles.

1. Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy;Li;Sci. Rep.,2017

2. New insights into the activities and toxicities of the old anticancer drug doxorubicin;van der Zanden;FEBS J.,2021

3. Autophagy-dependent sensitization of triple-negative breast cancer models to topoisomerase II poisons by inhibition of the nucleosome remodeling factor;Tyutyunyk-Massey;Mol. Cancer Res.,2021

4. Uncoupling DNA damage from chromatin damage to detoxify doxorubicin;Qiao;Proc. Natl. Acad. Sci. U. S. A.,2020

5. Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?;Campillo-Marcos;Cell. Mol. Life Sci.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear functions regulated by the VRK1 kinase;Nucleus;2024-05-16

2. VRK1 Regulates Sensitivity to Oxidative Stress by Altering Histone Epigenetic Modifications and the Nuclear Phosphoproteome in Tumor Cells;International Journal of Molecular Sciences;2024-04-30

3. Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy;Journal of Molecular Medicine;2024-03-30